|
|
||||||||
Ann Thorac Surg 2004;77:1494-1502
© 2004 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, Department of Surgery, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA
b Division of Cardiothoracic Surgery, Department of Surgery, Northwestern University, Chicago, Illinois, USA
c Section of Cardiothoracic Surgery, Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, USA
d Department of Thoracic and Cardiovascular Surgery, Lahey Clinic, Burlington, Massachusetts, USA
e Department of Cardiothoracic Surgery, University of Florida Medical Center, Jacksonville, Florida, USA
f Department of Cardiothoracic Surgery, Boston University Medical Center, Boston, Massachusetts, USA
g Heart Center of Indiana, Indianapolis, Indiana, USA
Accepted for publication January 14, 2004.
* Address reprint requests to Dr Bridges, 230 W. Washington Sq, Third Floor, Philadelphia, PA 19106, USA
e-mail: cbridges{at}pahosp.com
Abstract
BACKGROUND: Patients with chronic severe angina refractory to medical therapy who cannot be completely revascularized with either percutaneous catheter intervention or coronary artery bypass graft surgery present clinical challenges. Transmyocardial laser revascularization, either as sole therapy or as an adjunct to coronary artery bypass graft surgery, may be appropriate for some of these patients. Although transmyocardial revascularization has consistently been demonstrated as an efficacious means of relieving angina, the mechanism of its effects are still debated, and criteria for the selection of patients for this novel therapy have not been adequately defined.
METHODS: We reviewed the available evidence to allow us to make recommendations for the appropriate therapeutic applications of transmyocardial revascularization following the format of the American Heart Association and the American College of Cardiology guidelines for diagnostic and therapeutic procedures. Our recommendations were classified as class I, IIA, IIB, or III. For each recommendation we defined the level of supporting evidence as A, B, or C.
RESULTS: We identified class I indications for transmyocardial revascularization as sole therapy and class IIA indications for transmyocardial revascularization as an adjunct to coronary artery bypass graft surgery with levels of evidence A and B, respectively.
CONCLUSIONS: Transmyocardial laser revascularization may be an acceptable form of therapy for selected patients: as sole therapy for a subset of patients with refractory angina and as an adjunct to coronary artery bypass graft surgery for a subset of patients with angina who cannot be completely revascularized surgically.
This article has been cited by other articles:
![]() |
P. Atluri, C. M. Panlilio, G. P. Liao, E. E. Suarez, R. C. McCormick, W. Hiesinger, J. E. Cohen, M. J. Smith, A. B. Patel, W. Feng, et al. Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 283 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Horvath Light and Ice Cream Ann. Thorac. Surg., August 1, 2006; 82(2): 771 - 771. [Full Text] [PDF] |
||||
![]() |
K. A. Horvath, T. B. Ferguson Jr, R. A. Guyton, and F. H. Edwards Impact of Unstable Angina on Outcomes of Transmyocardial Laser Revascularization Combined With Coronary Artery Bypass Grafting Ann. Thorac. Surg., December 1, 2005; 80(6): 2082 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Pairolero Quality, Safety, and Transparency: A Rising Tide Floats All Boats Ann. Thorac. Surg., August 1, 2005; 80(2): 387 - 395. [Full Text] [PDF] |
||||
![]() |
G. S. Allen Mid-Term Results After Thoracoscopic Transmyocardial Laser Revascularization Ann. Thorac. Surg., August 1, 2005; 80(2): 553 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abrams Chronic Stable Angina N. Engl. J. Med., June 16, 2005; 352(24): 2524 - 2533. [Full Text] [PDF] |
||||
![]() |
A. Sanni and J. Dunning Is transmyocardial revascularisation of benefit in addition to coronary artery bypass grafting for patients with diffuse coronary disease? Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 581 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sanni and J. Dunning Is transmyocardial revascularisation of benefit to people with 'no option' angina? Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 586 - 592. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |